Form 8-K - Current report:
SEC Accession No. 0001193125-24-233067
Filing Date
2024-10-04
Accepted
2024-10-04 16:20:00
Documents
18
Period of Report
2024-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d893539d8k.htm   iXBRL 8-K 27209
2 EX-10.1 d893539dex101.htm EX-10.1 11909
3 EX-10.2 d893539dex102.htm EX-10.2 31951
4 EX-10.3 d893539dex103.htm EX-10.3 23248
5 EX-10.4 d893539dex104.htm EX-10.4 41903
9 GRAPHIC g893539g1004010158393.jpg GRAPHIC 1739
  Complete submission text file 0001193125-24-233067.txt   281806

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ndoi-20240930.xsd EX-101.SCH 2499
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndoi-20240930_lab.xml EX-101.LAB 15166
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndoi-20240930_pre.xml EX-101.PRE 9512
20 EXTRACTED XBRL INSTANCE DOCUMENT d893539d8k_htm.xml XML 3198
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 241355149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)